Most Recent
Liquidators have been appointed to a litigation funder behind a funding agreement ripped up by the court last year that would have given it a hefty 85 per cent commission.
Investors in Mayfair Group’s collapsed IPO Wealth Fund are set to recoup only a fraction of their alleged $67 million losses in a best-case settlement of a class action alleging the fund’s trustee misled unit holders.
Fintech Humm has admitted to making “misrepresentations” to Japanese bank SMBC over allegedly worthless receivables linked to Forum Finance but has denied it was negligent, claiming a Forum Group unit should share the burden of paying any damages in the $33.6 million lawsuit.
Crown Resorts has asked the court to appoint a contradictor to fight against a group costs order sought in shareholder class action accusing the casino giant of lax anti-money laundering compliance over a six-year period.
The University of Melbourne has hit back at the Fair Work Ombudsman’s allegations that it took adverse action against two casual academics to prevent them from claiming payment for extra hours worked, but admitted a supervisor penned an email referring to one of them as a “self-entitled Y-genner”.
Cable TV giant Foxtel has lost a protracted IP battle with subsidiary of global tech giant Cognizant over a digital download patent for a modern DVR system.
Despite objections from numerous group members, a judge has tossed an underpayments class action brought by a self-represented applicant against Wilson Security, ruling that class actions should not be run without lawyers.
For many in the legal profession the choice of Justice Jayne Jagot to replace the outgoing Justice Patrick Keane on the High Court, heralding a new era of judicial diversity on the top bench, was hardly a surprise.
Embattled investment firm Linchpin Capital has sued auditors Grant Thornton and Moore Stephens for signing off on the compliance plan for a registered fund that allegedly used investor money to advance the company's business interests and line its directors' pockets.
A judge has thrown out competing appeals of a decision finding Pfizer's patent for its post-operative injectable painkiller Dynastat is valid and that Australian drug maker Juno Pharmaceuticals infringed the patent by selling generic versions of the drug in Australia.